192 related articles for article (PubMed ID: 1703260)
21. An in vivo pharmacological study on muscarinic receptor subtypes regulating cholinergic neurotransmission in rat striatum.
Consolo S; Ladinsky H; Vinci R; Palazzi E; Wang JX
Biochem Pharmacol; 1987 Sep; 36(18):3075-7. PubMed ID: 2443145
[No Abstract] [Full Text] [Related]
22. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the muscarine receptors involved in the modulation of serotonin release from the vascularly perfused small intestine of guinea pig.
Schwörer H; Racké K; Kilbinger H
Naunyn Schmiedebergs Arch Pharmacol; 1989 Mar; 339(3):263-7. PubMed ID: 2471089
[TBL] [Abstract][Full Text] [Related]
24. Methoctramine selectively blocks cardiac muscarinic M2 receptors in vivo.
Wess J; Angeli P; Melchiorre C; Moser U; Mutschler E; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):246-9. PubMed ID: 3057387
[TBL] [Abstract][Full Text] [Related]
25. Presynaptic M2-muscarinic receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries.
Alonso MJ; Arribas S; Marín J; Balfagón G; Salaices M
Brain Res; 1991 Dec; 567(1):76-82. PubMed ID: 1726141
[TBL] [Abstract][Full Text] [Related]
26. Effects of pirenzepine and AF-DX 116 on ganglionic transmission in the cardiac sympathetic nerves of the dog: interaction of M1 and M2 receptors with nicotinic receptors.
Mukaiyama O; Takeuchi A; Kimura T; Satoh S
J Pharmacol Exp Ther; 1991 Feb; 256(2):525-9. PubMed ID: 1704433
[TBL] [Abstract][Full Text] [Related]
27. McN-A-343, a specific agonist of M1-muscarinic receptors, exerts antinicotinic and antimuscarinic effects in the rat adrenal medulla.
Wakade AR; Kahn R; Malhotra RK; Wakade CG; Wakade TD
Life Sci; 1986 Dec; 39(22):2073-80. PubMed ID: 2431246
[TBL] [Abstract][Full Text] [Related]
28. Different effects of muscarinic agonists in rat superior cervical ganglion and hippocampal slices.
Boddeke HW
Eur J Pharmacol; 1991 Aug; 201(2-3):191-7. PubMed ID: 1724649
[TBL] [Abstract][Full Text] [Related]
29. Distinct muscarinic receptor subtypes differentially modulate acetylcholine release from corticocerebral synaptosomes.
Pittel Z; Heldman E; Rubinstein R; Cohen S
J Neurochem; 1990 Aug; 55(2):665-72. PubMed ID: 1695243
[TBL] [Abstract][Full Text] [Related]
30. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
Witkin JM
Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
[TBL] [Abstract][Full Text] [Related]
31. Selective blockade of muscarinic M2 receptors in vivo by the new antagonist tripitramine.
Angeli P; Cantalamessa F; Gulini U; Melchiorre C
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):304-7. PubMed ID: 8584046
[TBL] [Abstract][Full Text] [Related]
32. Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanisms.
Lazartigues E; Brefel-Courbon C; Tran MA; Montastruc JL; Rascol O
Br J Pharmacol; 1999 Aug; 127(7):1657-65. PubMed ID: 10455323
[TBL] [Abstract][Full Text] [Related]
33. Modulation of synaptic transmission in autonomic ganglia mediated via the activation of postganglionic muscarinic M1 receptors.
Galvan M
Pharmacology; 1988; 37 Suppl 1():11-6. PubMed ID: 2467314
[TBL] [Abstract][Full Text] [Related]
34. Regional differences in the coupling of muscarinic receptors to inositol phospholipid hydrolysis in guinea pig brain.
Fisher SK; Bartus RT
J Neurochem; 1985 Oct; 45(4):1085-95. PubMed ID: 2411866
[TBL] [Abstract][Full Text] [Related]
35. Subclassification of muscarinic receptors in the heart, urinary bladder and sympathetic ganglia in the pithed rat. Selectivity of some classical agonists.
van Charldorp KJ; de Jonge A; Thoolen MJ; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):301-6. PubMed ID: 4094621
[TBL] [Abstract][Full Text] [Related]
36. Release of endogenous acetylcholine from a vascularly perfused rat stomach in vitro; inhibition by M3 muscarinic autoreceptors and alpha-2 adrenoceptors.
Yokotani K; Okuma Y; Nakamura K; Osumi Y
J Pharmacol Exp Ther; 1993 Sep; 266(3):1190-5. PubMed ID: 7690397
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the antimuscarinic effects of pirenzepine and N-methylatropine on ganglionic and vascular muscarinic receptors in the rat.
Wess J; Lambrecht G; Moser U; Mutschler E
Life Sci; 1984 Jul; 35(5):553-60. PubMed ID: 6379356
[TBL] [Abstract][Full Text] [Related]
38. Central oxotremorine antagonist properties of pirenzepine.
Witkin JM; Alvarado-Garcia R; Perez LA; Witkin KM
Life Sci; 1988; 42(24):2467-73. PubMed ID: 3374266
[TBL] [Abstract][Full Text] [Related]
39. M1 muscarinic receptor stimulation decreases aspartate release in the rat neostriatum.
Expósito I; Sanz B; Mora F
Neurochem Res; 1997 Dec; 22(12):1485-90. PubMed ID: 9357014
[TBL] [Abstract][Full Text] [Related]
40. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
